Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions

View ORCID ProfileManon Ragonnet-Cronin, View ORCID ProfileOlivia Boyd, View ORCID ProfileLily Geidelberg, View ORCID ProfileDavid Jorgensen, View ORCID ProfileFabricia F Nascimento, View ORCID ProfileIgor Siveroni, Robert Johnson, View ORCID ProfileMarc Baguelin, Zulma M Cucunuba, View ORCID ProfileElita Jauneikaite, View ORCID ProfileSwapnil Mishra, View ORCID ProfileHayley A Thompson, View ORCID ProfileOliver J Watson, Neil Ferguson, View ORCID ProfileChristl A Donnelly, View ORCID ProfileErik Volz
doi: https://doi.org/10.1101/2020.09.15.20194258
Manon Ragonnet-Cronin
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manon Ragonnet-Cronin
  • For correspondence: manonragonnet@imperial.ac.uk
Olivia Boyd
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivia Boyd
  • For correspondence: o.boyd@imperial.ac.uk
Lily Geidelberg
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lily Geidelberg
David Jorgensen
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Jorgensen
Fabricia F Nascimento
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fabricia F Nascimento
Igor Siveroni
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Igor Siveroni
Robert Johnson
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Baguelin
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Baguelin
Zulma M Cucunuba
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elita Jauneikaite
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elita Jauneikaite
Swapnil Mishra
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Swapnil Mishra
Hayley A Thompson
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hayley A Thompson
Oliver J Watson
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oliver J Watson
Neil Ferguson
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christl A Donnelly
2 Imperial College London; University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christl A Donnelly
Erik Volz
1 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik Volz
  • For correspondence: e.volz@imperial.ac.uk
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: Unprecedented public health interventions including travel restrictions and national lockdowns have been implemented to stem the COVID-19 epidemic, but the effectiveness of non-pharmaceutical interventions is still debated. International comparisons are hampered by highly variable conditions under which epidemics spread and differences in the timing and scale of interventions. Cumulative COVID-19 morbidity and mortality are functions of both the rate of epidemic growth and the duration of uninhibited growth before interventions were implemented. Incomplete and sporadic testing during the early COVID-19 epidemic makes it difficult to identify how long SARS-CoV-2 was circulating in different places. SARS-CoV-2 genetic sequences can be analyzed to provide an estimate of both the time of epidemic origin and the rate of early epidemic growth in different settings. Methods: We carried out a phylogenetic analysis of more than 29,000 publicly available whole genome SARS-CoV-2 sequences from 57 locations to estimate the time that the epidemic originated in different places. These estimates were cross-referenced with dates of the most stringent interventions in each location as well as the number of cumulative COVID-19 deaths following maximum intervention. Phylodynamic methods were used to estimate the rate of early epidemic growth and proxy estimates of epidemic size. Findings: The time elapsed between epidemic origin and maximum intervention is strongly associated with different measures of epidemic severity and explains 46% of variance in numbers infected at time of maximum intervention. The reproduction number is independently associated with epidemic severity. In multivariable regression models, epidemic severity was not associated with census population size. The time elapsed between detection of initial COVID-19 cases to interventions was not associated with epidemic severity, indicating that many locations experienced long periods of cryptic transmission. Interpretation: Locations where strong non-pharmaceutical interventions were implemented earlier experienced much less severe COVID-19 morbidity and mortality during the period of study.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MRC is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and this award is part of the EDCTP2 programme supported by the European Union (MR/R015600/1). RJ and EV acknowledge funding from the European Commission (CoroNAb 101003653). EV additionally acknowledges funding from the Wellcome Trust (220885/Z/20/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Analyses were conducted entirely on anonymous, publicly available data from GISAID and other public databases.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All genetic data are publicly available upon registration with GISAID (https://www.gisaid.org/). Details for non-genetic data are provided in our Supplementary Materials.

https://www.gisaid.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions
Manon Ragonnet-Cronin, Olivia Boyd, Lily Geidelberg, David Jorgensen, Fabricia F Nascimento, Igor Siveroni, Robert Johnson, Marc Baguelin, Zulma M Cucunuba, Elita Jauneikaite, Swapnil Mishra, Hayley A Thompson, Oliver J Watson, Neil Ferguson, Christl A Donnelly, Erik Volz
medRxiv 2020.09.15.20194258; doi: https://doi.org/10.1101/2020.09.15.20194258
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COVID-19 epidemic severity is associated with timing of non-pharmaceutical interventions
Manon Ragonnet-Cronin, Olivia Boyd, Lily Geidelberg, David Jorgensen, Fabricia F Nascimento, Igor Siveroni, Robert Johnson, Marc Baguelin, Zulma M Cucunuba, Elita Jauneikaite, Swapnil Mishra, Hayley A Thompson, Oliver J Watson, Neil Ferguson, Christl A Donnelly, Erik Volz
medRxiv 2020.09.15.20194258; doi: https://doi.org/10.1101/2020.09.15.20194258

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)